Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
2598 | 2 | LEVOSIMENDAN//CALCIUM SENSITIZER//MILRINONE | 3876 |
2621 | 1 | ENOXIMONE//MILRINONE//AMRINONE | 2220 |
11088 | 1 | LEVOSIMENDAN//CALCIUM SENSITIZER//PIMOBENDAN | 1037 |
24654 | 1 | VESNARINONE//TSC 22//POSITIVE INOTROPIC ACTIVITY | 328 |
34361 | 1 | BDF 9148//DPI 201 106//NA CHANNEL ACTIVATOR | 126 |
35398 | 1 | FLOSEQUINAN//BTS 53 554//DIPARTIMENTO SCI FARMACOBIOL COMPLESSO NINI BARBI | 112 |
38782 | 1 | VARITRIOL//ORGAN CHEM CPC 2//LUNG CARCINOMA A549 CELL LINE | 53 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | LEVOSIMENDAN | authKW | 2755604 | 10% | 85% | 400 |
2 | CALCIUM SENSITIZER | authKW | 581506 | 2% | 84% | 85 |
3 | MILRINONE | authKW | 388039 | 3% | 39% | 124 |
4 | ENOXIMONE | authKW | 308017 | 2% | 63% | 60 |
5 | VESNARINONE | authKW | 299277 | 1% | 78% | 47 |
6 | PIMOBENDAN | authKW | 238881 | 1% | 64% | 46 |
7 | AMRINONE | authKW | 228930 | 1% | 54% | 52 |
8 | CA2 SENSITIZER | authKW | 210769 | 1% | 79% | 33 |
9 | INOTROPIC AGENTS | authKW | 189200 | 2% | 29% | 79 |
10 | TSC 22 | authKW | 169354 | 1% | 83% | 25 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 38676 | 39% | 0% | 1525 |
2 | Pharmacology & Pharmacy | 13117 | 35% | 0% | 1348 |
3 | Anesthesiology | 3221 | 6% | 0% | 225 |
4 | Chemistry, Medicinal | 3128 | 9% | 0% | 351 |
5 | Peripheral Vascular Diseases | 2511 | 8% | 0% | 314 |
6 | Critical Care Medicine | 1319 | 4% | 0% | 152 |
7 | Respiratory System | 625 | 4% | 0% | 152 |
8 | Medicine, General & Internal | 544 | 7% | 0% | 276 |
9 | Physiology | 54 | 2% | 0% | 91 |
10 | Chemistry, Multidisciplinary | 18 | 5% | 0% | 188 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ORGAN CHEM CPC 2 | 51762 | 0% | 58% | 11 |
2 | CRIT CARE PROPRIETARY PROD | 48776 | 0% | 100% | 6 |
3 | CARDIOVASC PROJECTS | 40647 | 0% | 100% | 5 |
4 | CARDIOTHORAC ANAESTHESIA INTENS CARE UNIT | 18290 | 0% | 75% | 3 |
5 | DIPARTIMENTO SCI FARMACOBIOL COMPLESSO NINI BARBI | 18290 | 0% | 75% | 3 |
6 | NAT OURCES FUNCT MOL CHANGBAI MT | 16942 | 0% | 19% | 11 |
7 | ANAESTHESIA INTENS CAREUMR 942 | 16259 | 0% | 100% | 2 |
8 | ANESTHESIOL SCI CRIT MED PAIN THER Y | 16259 | 0% | 100% | 2 |
9 | BLOOMSBURY INTENS CARE | 16259 | 0% | 100% | 2 |
10 | HEART FAILURE CLIN ECHO | 16259 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 51111 | 7% | 2% | 264 |
2 | CARDIOVASCULAR DRUGS AND THERAPY | 14294 | 2% | 3% | 59 |
3 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 9936 | 2% | 2% | 72 |
4 | ZEITSCHRIFT FUR KARDIOLOGIE | 9208 | 2% | 2% | 68 |
5 | AMERICAN HEART JOURNAL | 7542 | 3% | 1% | 117 |
6 | CARDIOVASCULAR DRUG REVIEWS | 6951 | 0% | 5% | 19 |
7 | AMERICAN JOURNAL OF CARDIOLOGY | 5879 | 4% | 1% | 142 |
8 | JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 4001 | 1% | 1% | 45 |
9 | CIRCULATION | 3849 | 3% | 0% | 110 |
10 | HERZ KREISLAUF | 3632 | 1% | 2% | 21 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LEVOSIMENDAN | 2755604 | 10% | 85% | 400 | Search LEVOSIMENDAN | Search LEVOSIMENDAN |
2 | CALCIUM SENSITIZER | 581506 | 2% | 84% | 85 | Search CALCIUM+SENSITIZER | Search CALCIUM+SENSITIZER |
3 | MILRINONE | 388039 | 3% | 39% | 124 | Search MILRINONE | Search MILRINONE |
4 | ENOXIMONE | 308017 | 2% | 63% | 60 | Search ENOXIMONE | Search ENOXIMONE |
5 | VESNARINONE | 299277 | 1% | 78% | 47 | Search VESNARINONE | Search VESNARINONE |
6 | PIMOBENDAN | 238881 | 1% | 64% | 46 | Search PIMOBENDAN | Search PIMOBENDAN |
7 | AMRINONE | 228930 | 1% | 54% | 52 | Search AMRINONE | Search AMRINONE |
8 | CA2 SENSITIZER | 210769 | 1% | 79% | 33 | Search CA2+SENSITIZER | Search CA2+SENSITIZER |
9 | INOTROPIC AGENTS | 189200 | 2% | 29% | 79 | Search INOTROPIC+AGENTS | Search INOTROPIC+AGENTS |
10 | TSC 22 | 169354 | 1% | 83% | 25 | Search TSC+22 | Search TSC+22 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |